FDC

Price chart

Previous close

₹392.60

Open

₹392.60

Day high

₹395.45

Day low

₹389.50

Listed on NSE since 7 August 1997.

Market value

₹6,413.90 Cr

P/E (trailing)

20.61

EPS (trailing)

₹19.11

Price to book

2.41

Dividend yield

2.55%

Return on equity

12.3%

Debt to equity

0.00

Profit margin

13.7%

Beta

0.11

Volume today

79,360

Average volume

1.87 L

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Source: FDC’s results filed with NSE, consolidated (the whole group). Net profit is the share of FDC’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Source: FDC’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.

FDC Limited, together with its subsidiaries, manufactures and trades in pharmaceutical products in India, the United States, and internationally. The company offers pharmaceutical formulations for various therapeutic segments, including anti-infectives, gastroenterology, ophthalmology, anti-diabetics, cardiovascular care, respiratory care, gynaecology, dermatology, paediatrics, analgesics, vitamins, and nutritional health in the form of tablets, capsules, oral liquids, ophthalmic drops, topical preparations, and paediatric-friendly solutions. It also provides functional food, such as flavoured oral rehydration solution powders, ready-to-drink electrolyte beverages, vitamin-enriched supplements, antioxidant blends and protein-fortified drinks; and various active pharmaceutical ingredients. The company sells its products under the Zifi, Zifi-0, Zocon, Mycoderm, Zathrin, Victofol, Cotaryl, Ziglim-M, Amodep-AT, MumMum 1, Victofol Injection, Simyl MCT, Victofol – C, Electral, and Enerzal brands. It also exports its products to approximately 50 countries. FDC Limited was founded in 1936 and is based in Mumbai, India.

Industry

Drug Manufacturers - Specialty & Generic

Based in

Mumbai

Employees

7,076

Company website · Profile: Yahoo Finance

No headlines name FDC in the last day or two.

• Buy Back

  Buyback · ex-date 13 November 2026

• Interim Dividend - Rs 5 Per Share

  Dividend · ex-date 11 February 2026

• Interim Dividend - Rs 5 Per Share

  Dividend · ex-date 22 November 2024

• Annual General Meeting

  Action · ex-date 19 September 2024

• Annual General Meeting

  Action · ex-date 20 September 2023

• Buy Back

  Buyback · ex-date 25 August 2023

• Annual General Meeting

  Action · ex-date 13 September 2022

• Buy Back

  Buyback · ex-date 17 February 2022 · record date 19 February 2022

Source: NSE. Latest first, 8 of 20.